miR-379 Regulates Cyclin B1 Expression and Is Decreased in Breast Cancer

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Khan, Sonja ^a   Brougham, Cathy L ^a   Ryan, James ^a   Sahrudin, Arisha ^a   O'Neill, Gregory ^a   Wall, Deirdre ^a   Curran, Catherine ^a   Newell, John ^a   Kerin, Michael J ^a   Dwyer, Roisin M ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; MICRORNA; MIR 379; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; CELL PROLIFERATION; CYCLIN B1; FEMALE; FIBROADENOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MIDDLE AGED; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84880000751     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068753     Document Type: Article

References (34)

1. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297. doi:10.1016/S0092-8674(04)00045-5. PubMed: 14744438.
2. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773. doi:10.1038/nature03315. PubMed: 15685193.
3. Zeng Y, Yi R, Cullen BR, (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A 100: 9779-9784. doi:10.1073/pnas.1630797100. PubMed: 12902540.
4. Sassen S, Miska EA, Caldas C, (2008) MicroRNA: implications for cancer. Virchows Arch 452: 1-10. doi:10.1007/s00428-007-0532-2. PubMed: 18040713.
5. Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ, (2010) Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15: 673-682. doi:10.1634/theoncologist.2010-0103. PubMed: 20576643.
6. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866. doi:10.1038/nrc1997. PubMed: 17060945.
7. Pollari S, Leivonen SK, Perälä M, Fey V, Käkönen SM, et al. (2012) Identification of microRNAs inhibiting TGF-beta-induced IL-11 production in bone metastatic breast cancer cells. PLOS ONE 7: e37361. doi:10.1371/journal.pone.0037361. PubMed: 22629385.
8. Kawamoto H, Koizumi H, Uchikoshi T, (1997) Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses. Am J Pathol 150: 15-23. PubMed: 9006317.
9. Rudolph P, Kühling H, Alm P, Fernö M, Baldetorp B, et al. (2003) Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer. Int J Cancer 105: 674-680. doi:10.1002/ijc.11132. PubMed: 12740917.
10. Kühling H, Alm P, Olsson H, Fernö M, Baldetorp B, et al. (2003) Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer. J Pathol 199: 424-431. doi:10.1002/path.1322. PubMed: 12635132.
11. Aaltonen K, Amini RM, Landberg G, Eerola H, Aittomäki K, et al. (2009) Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer. Breast Cancer Res Treat 113: 75-82. doi:10.1007/s10549-008-9908-5. PubMed: 18240019.
12. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105. PubMed: 18955434.
13. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLOS Biol 2: e363. doi:10.1371/journal.pbio.0020363. PubMed: 15502875.
14. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. doi:10.1016/j.cell.2004.12.035. PubMed: 15652477.
15. Pines J, Hunter T, (1990) Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature 346: 760-763. doi:10.1038/346760a0. PubMed: 2143810.
16. Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, et al. (2009) Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin Cancer Res 15: 3654-3662. doi:10.1158/1078-0432.CCR-08-3293. PubMed: 19470724.
17. Murakami H, Furihata M, Ohtsuki Y, Ogoshi S, (1999) Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch 434: 153-158. doi:10.1007/s004280050319. PubMed: 10071250.
18. Nozoe T, Korenaga D, Kabashima A, Ohga T, Saeki H, et al. (2002) Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus. Clin Cancer Res 8: 817-822. PubMed: 11895914.
19. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, et al. (2000) Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 60: 4000-4004. PubMed: 10945597.
20. Yoshida T, Tanaka S, Mogi A, Shitara Y, Kuwano H, (2004) The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann Oncol 15: 252-256. doi:10.1093/annonc/mdh073. PubMed: 14760118.
21. Ikuerowo SO, Kuczyk MA, Mengel M, van der Heyde E, Shittu OB, et al. (2006) Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients. Int J Cancer 119: 867-874. doi:10.1002/ijc.21869. PubMed: 16557593.
22. Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, et al. (2002) Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res 62: 6414-6417. PubMed: 12438226.
23. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, et al. (2002) Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer 94: 2874-2881. doi:10.1002/cncr.10542. PubMed: 12115375.
24. Yuan J, Yan R, Krämer A, Eckerdt F, Roller M, et al. (2004) Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene 23: 5843-5852. doi:10.1038/sj.onc.1207757. PubMed: 15208674.
25. Androic I, Krämer A, Yan R, Rödel F, Gätje R, et al. (2008) Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol. BMC Cancer 8: 391. doi:10.1186/1471-2407-8-391. PubMed: 19113992.
26. Huang V, Place RF, Portnoy V, Wang J, Qi Z, et al. (2012) Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res 40: 1695-1707. doi:10.1093/nar/gkr934. PubMed: 22053081.
27. Yamanaka S, Campbell NR, An F, Kuo SC, Potter JJ, et al. (2012) Coordinated effects of microRNA-494 induce G(2)/M arrest in human cholangiocarcinoma. Cell Cycle 11: 2729-2738. doi:10.4161/cc.21105. PubMed: 22785131.
28. Gattolliat CH, Thomas L, Ciafrè SA, Meurice G, Le Teuff G, et al. (2011) Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. Br J Cancer 105: 1352-1361. doi:10.1038/bjc.2011.388. PubMed: 21970883.
29. Schwarzenbach H, Hoon DS, Pantel K, (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11: 426-437. doi:10.1038/nrc3066. PubMed: 21562580.
30. Ryan J, Curran CE, Hennessy E, Newell J, Morris JC, et al. (2011) The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue. PLOS ONE 6: e16023. doi:10.1371/journal.pone.0016023. PubMed: 21283523.
31. Heneghan HM, Miller N, Kerin MJ, (2010) Systemic microRNAs: novel biomarkers for colorectal and other cancers? Gut 59: 1002-1004; author reply 1004. doi:10.1136/gut.2009.200121. PubMed: 20581247.
32. McNeill RE, Miller N, Kerin MJ, (2007) Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer. BMC Mol Biol 8: 107. doi:10.1186/1471-2199-8-107. PubMed: 18042273.
33. Davoren PA, McNeill RE, Lowery AJ, Kerin MJ, Miller N, (2008) Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 9: 76. doi:10.1186/1471-2199-9-76. PubMed: 18718003.
34. Roa W, Brunet B, Guo L, Amanie J, Fairchild A, et al. (2010) Identification of a new microRNA expression profile as a potential cancer screening tool. Clin Invest Med 33: E124. PubMed: 20370992.